ORANGEBURG, N.Y., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the publication of positive outcomes of a clinical study that evaluated the durability and microbial barrier properties of the Company's EndoSheath ® technology in the flexible cystoscopy setting in the November issue of the peer-reviewed journal BMC Urology. To assess the efficacy of Vision-Sciences' EndoSheath technology with flexible cystoscopes, study authors tested the barrier integrity of each EndoSheath disposable following clinical procedures and then performed microbiology sampling of the flexible cystoscopes to determine if any bacterial contamination had occurred. Study outcomes and conclusions include:
- 100% of EndoSheath units tested were leak-free following clinical use. This finding confirms outcomes of a prior study of 875 endoscopic procedures in which no leaks were reported.
- 100% of microbiology samples showed a clean flexible cystoscope following EndoSheath technology usage and the Company's recommended cleaning procedure.
- The study authors concluded that Vision-Sciences' reprocessing procedure featured a low risk of pathogen transmission, high-patient safety and a valid alternative to the recommended high-level disinfection procedure of competitive flexible cystoscopes.